Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday

Source The Motley Fool

Thanks largely to news of a crucial legal settlement, GSK (NYSE: GSK) was one of the better-performing big pharma stocks on Wednesday. Relieved investors showed their appreciation by collectively bidding the company's shares up by 5.8% on the day, a performance that easily eclipsed the 0.7% rise of the benchmark S&P 500 index.

$2.2 billion-plus in settlements

That news concerns a discontinued version of GSK's blockbuster heartburn drug Zantac, which was the focus of a series of lawsuits alleging that its active ingredient caused cancer. GSK announced Wednesday that it has agreed to a settlement with 10 plaintiffs' law firms representing around 80,000 Zantac cases -- 93% of the total number. The agreement will see the pharmaceutical company make a maximum aggregate payment of $2.2 billion to resolve all of those cases.

GSK added that other terms of the settlement were confidential. The company wrote that it expects the settlement to be fully implemented by the end of the first half of 2025.

Additionally, GSK has agreed in principle to settle a whistleblower lawsuit brought by Valisure, a laboratory based in Connecticut, with a $70 million payment. Similar to the cases in the other settlement, Valisure had accused the company of concealing the risks of cancer associated with Zantac.

Not admitting liability

At one point, the heavily marketed Zantac was the best-selling drug in the world. First approved in the U.S. in 1983, its long run ended in 2020 when the Food and Drug Administration asked its makers to remove it from the market. This was on concerns that the active ingredient, ranitidine, could degenerate into a carcinogenic substance under certain circumstances.

In its press release on the settlements, GSK stressed that it has not admitted liability in either instance.

It added, "While the scientific consensus remains that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer, GSK strongly believes that these settlements are in the best long-term interests of the company and its shareholders, as they remove significant financial uncertainty, risk, and distraction associated with protracted litigation."

Don’t miss this second chance at a potentially lucrative opportunity

Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this.

On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves:

  • Amazon: if you invested $1,000 when we doubled down in 2010, you’d have $20,579!*
  • Apple: if you invested $1,000 when we doubled down in 2008, you’d have $42,710!*
  • Netflix: if you invested $1,000 when we doubled down in 2004, you’d have $389,239!*

Right now, we’re issuing “Double Down” alerts for three incredible companies, and there may not be another chance like this anytime soon.

See 3 “Double Down” stocks »

*Stock Advisor returns as of October 7, 2024

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends GSK. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Bitcoin Plunges 13% in a Week as Market Retreats to $60,000 LevelBitcoin plunged 13% over the past seven days as bullish defense lines crumbled in succession, officially kicking off the battle to defend the $60,000 mark.On November 16, following a viol
Author  TradingKey
8 hours ago
Bitcoin plunged 13% over the past seven days as bullish defense lines crumbled in succession, officially kicking off the battle to defend the $60,000 mark.On November 16, following a viol
placeholder
Silver Price Falls Below $50 to Hit Near One-Year Low: Why Is Silver Falling? As of the Asian session on Monday (November 16), silver prices (XAGUSD) extended their recent decline, falling for the third consecutive trading day and dropping nearly 3% intraday to tra
Author  TradingKey
10 hours ago
As of the Asian session on Monday (November 16), silver prices (XAGUSD) extended their recent decline, falling for the third consecutive trading day and dropping nearly 3% intraday to tra
placeholder
Silver Price Forecast: XAG/USD hits yearly lows below $47.50 amid hawkish Fed sentimentSilver price (XAG/USD) extends its losses for the third successive day, trading around $47.50 per troy ounce during Asian hours on Monday. Silver prices fell to a yearly low of $47.34, pressured by a strengthening US Dollar (USD) and elevated Treasury yields.
Author  FXStreet
13 hours ago
Silver price (XAG/USD) extends its losses for the third successive day, trading around $47.50 per troy ounce during Asian hours on Monday. Silver prices fell to a yearly low of $47.34, pressured by a strengthening US Dollar (USD) and elevated Treasury yields.
placeholder
Weekly Report: DXY 103.41, 10-year 5.15%, AUD carry 3bp — three FX regimes flipped in one weekThe dollar index rose 1.09% to 103.41, a 19-month high, while the US 10-year closed at 5.154% and the Australia-US two-year spread collapsed to about 3 basis points from 36. EURUSD fell 1.59% to 1.1024, USDJPY rose 1.51% to 159.78 and AUDUSD fell 1.79% to 0.6764, a 10-month low. Three FX regimes — the broad dollar, the US rate level and the Australian carry premium — flipped in the same week. This report marks the thresholds, ranks which one can flip back first, and lists the week's calendar.
Author  Irene Q.
15 hours ago
The dollar index rose 1.09% to 103.41, a 19-month high, while the US 10-year closed at 5.154% and the Australia-US two-year spread collapsed to about 3 basis points from 36. EURUSD fell 1.59% to 1.1024, USDJPY rose 1.51% to 159.78 and AUDUSD fell 1.79% to 0.6764, a 10-month low. Three FX regimes — the broad dollar, the US rate level and the Australian carry premium — flipped in the same week. This report marks the thresholds, ranks which one can flip back first, and lists the week's calendar.
placeholder
Weekly Report: Gold's $4,000 reclaim and Brent's $100 break were right calls — the silver call was wrongLast week this report said gold's $4,000 reclaim was not the trend and that Brent's supply premium was over. Gold fell 4.7% to $3,884.69 and Brent fell 2.52% to $95.84, so both were right. The call that missed was silver: we read a gold-silver ratio of 78.7 as silver being cheap, and the ratio instead broke above 80 to 81.1 as silver fell 5.35%. This report grades the three calls, explains the miss, and sets this week's scorecard around 3,852 gold, 93.73 Brent and 6.00 copper.
Author  Irene Q.
16 hours ago
Last week this report said gold's $4,000 reclaim was not the trend and that Brent's supply premium was over. Gold fell 4.7% to $3,884.69 and Brent fell 2.52% to $95.84, so both were right. The call that missed was silver: we read a gold-silver ratio of 78.7 as silver being cheap, and the ratio instead broke above 80 to 81.1 as silver fell 5.35%. This report grades the three calls, explains the miss, and sets this week's scorecard around 3,852 gold, 93.73 Brent and 6.00 copper.
goTop
quote